Work

Docetaxel chemotherapy remains the standard of care in castration-resistant prostate cancer

Year: 2008

Type: article

Source: Nature Clinical Practice Oncology

DOI: 10.1038/ncponc1201

Authors: Brian Schurko, William K Oh

Institutions: Dana-Farber Cancer Institute, Harvard University, Dana-Farber/Harvard Cancer Center, Dana-Farber Brigham Cancer Center

Language: English

Topic: Prostate Cancer Treatment and Research

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2055523013

FWCI: 3.377

Cites: 5

Cited by: 28

Related to: 10